The number of atrial fibrillation (AFib) cases is expected to double, or even triple, by 2050 as the global population continues to age.1 To help mitigate the growing clinical burden, cardiology providers must implement innovations in the diagnostic process that accelerate the time to treatment.
Read More »
Abby Massey
The number of atrial fibrillation (AFib) cases is expected to double, or even triple, by 2050 as the global population continues to age.1 To help mitigate the growing clinical burden, cardiology providers must implement innovations in the diagnostic process that accelerate the time to treatment.
Dr. Robert Hauser
SARS-CoV-2 most notably causes respiratory symptoms, but the virus can infect almost any organ in the body.1 With almost four years of data on the COVID-19 pandemic, physicians and researchers alike are closely monitoring how the disease progresses from short-term infections to long-term complications.
Abby Massey
Sudden cardiac arrest (SCA) can occur without warning or prior indication of heart disease. The disrupted blood flow interferes with oxygen delivery to vital organs, which can quickly become fatal if the heart is not resuscitated.
SCA is the leading medical cause of death on school campuses and is especially common among student athletes.1 The CDC estimates that SCA is responsible for 2,000 deaths every year in patients under 25 years old.2
Dr. Robert Hauser
Clinical atrial fibrillation (AF) is associated with increased rates of stroke, heart failure, mortality, hospitalization, and cognitive decline. For years oral anticoagulation and rate control have been the mainstays of treatment. But now, with the advent of new techniques, AF ablation has become a safe and effective method for maintaining sinus rhythm. The challenge for practitioners is to identify AF in their patients as soon as possible so that the proper management strategy can be implemented early in the course of the disease.
A patient wearing Cardea SOLO
When doctors outsource for test results, the “wait” begins for the provider and staff, as well as for the anxious patient. In many cases, the delay to get the results back is measured in days, but some types of outsourced tests can often take weeks. One of the most notable testing delays in the industry occurs in outsourced electrocardiogram (ECG) testing. Ambulatory ECG testing is prescribed in order to rule out abnormal cardiac rhythms in symptomatic or high-risk patients. As longer duration, multi-day prescription ambulatory ECG test recordings are being increasingly prescribed versus traditional, cabled 1- or 2-day Holter ECG recorders, this shift has led to increased IDTF technical analysis outsourcing to handle large amounts of ECG data.
5 Ways Cardiac Insight is Expanding Access to AFib Diagnosis and Treatment
To find the right solution, you must first know a problem exists. During AFib (Atrial Fibrillation) Awareness Month this September, cardiologists, electrophysiologists, clinicians, and the wider cardiology community including Cardiac Insight are raising awareness and a collective voice to ensure the public understands the magnitude and seriousness of AFib.
AFib is the occurrence of a quivering or irregular heartbeat (arrhythmia) that often leads to blood clots, stroke, heart failure and even death. The toll it takes on patients, their loved ones, and the healthcare system is extreme. AFib alone increases a person’s risk of stroke by 500 percent, yet most people are not even aware that it is a serious condition (Source: AHA). Far too often, it’s left undetected and untreated.
Dave Hadley, PhD, Senior VP of Research & Development
Waves, whether transmitted through bedrock or heart muscle, often forecast future events. But you must know how to listen and leverage the right technology. Analyzing waves to understand source characteristics has always fascinated me.
My career has its very early foundation in what’s under our feet, not beating in our chest. I started my career as a seismologist. The underlying physics associated with seismic waves are very similar to the electrical waves pulsing through cardiac muscle.
Nathan Hutchinson Regional Sales Director
The idea of “Continuity of Patient Care” is extending further past the four walls of the hospital, past the physician office or clinic, into the patient’s home and beyond. Patients can access advanced care and testing in a growing number of diverse settings, including freestanding urgent care, emergency rooms and more recently even in pharmacies. People are more mobile than ever. Our collective efforts should work towards ensuring our individual health record story is just as mobile, as well as accurate and complete. Simple, right? Maybe not so much, but it’s getting there.
Stacy Sprouse, Vice President of Sales
The continued risks and uncertainty of COVID-19 are wreaking havoc on many organizations. The decisions we make today, next week and even next month will have far-reaching impact. In my view, the highest priority is the health and safety of everyone. Clinics and hospitals are temporarily shut down or requiring employees to work from home, experimenting with new communication techniques, or taking whatever actions are available in order to operate.
Visit our blog to read and learn from industry leaders in cardiovascular medicine, the advancement and debate in wearable diagnostic technology as well as personal stories from our customers and employees.
Sign up to stay informed on the latest from Cardiac Insight.
Cardea SOLO™ is an all-inclusive wearable ECG patch that provides physicians immediate access to patient ECG data.
Cardea 20/20 ECG™ is the only reliable, automated diagnostic system designed to identify cardiac conditions associated with sudden cardiac death in active youth and athletes.